OREGON CITY, Ore., Oct. 5, 2021 (SEND2PRESS NEWSWIRE) — When Dee Lake found out she had an aggressive form of breast cancer this past September, she decided to take matters into her own hands. Not typically the type of person to ask for help, she put her qualms aside and launched a GoFundMe campaign where […]
LOS ANGELES, Calif. /California Newswire/ — ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients. Originally published […]
LOS ANGELES, Calif., April 2, 2020 (SEND2PRESS NEWSWIRE) — ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural […]
